Jesse M Jaso

Medicine & Life Sciences

1. Lymphoma 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 73%
3. Primary Myelofibrosis 62%
4. Myelodysplastic Syndromes 56%
5. B-Cell Lymphoma 55%
6. Bone Marrow 51%
7. Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 43%
8. Lymphomatoid Granulomatosis 40%
9. Mucin-5B 40%
10. Subdural Space 38%
11. Primary Effusion Lymphoma 37%
12. Sensitivity and Specificity 37%
13. Leukemia, Myelomonocytic, Chronic 36%
14. Marginal Zone B-Cell Lymphoma 36%
15. African Trypanosomiasis 35%
16. Breast Implants 33%
17. Hematologic Neoplasms 33%
18. Anaplastic Large-Cell Lymphoma 33%
19. Lenalidomide 33%
20. Radiotherapy 32%
21. Human Herpesvirus 8 32%
22. Subdural Hematoma 31%
23. Adenoid Cystic Carcinoma 31%
24. Non-Hodgkin's Lymphoma 31%
25. Immunophenotyping 31%
26. Erythrocyte Count 31%
27. Survival 30%
28. Burkitt Lymphoma 30%
29. Electroporation 29%
30. Natural Killer T-Cells 29%
31. Residual Neoplasm 29%
32. Lymphoproliferative Disorders 29%
33. T-Cell Lymphoma 28%
34. Pathology 28%
35. Cytogenetics 28%
36. Self-Assessment 28%
37. Blood Coagulation 28%
38. Osteomyelitis 27%
39. Hematology 26%
40. Mucus 26%
41. Sleepiness 26%
42. Stem Cell Transplantation 26%
43. Recurrence 26%
44. Transplants 25%
45. Thyroid Gland 24%
46. Oncogenes 23%
47. Central Nervous System 23%
48. Protein-Tyrosine Kinases 22%
49. Staphylococcus aureus 21%
50. Cefazolin 20%